Outcome of High-Risk Stage 3 Neuroblastoma with Myeloablative Therapy and 13-cis-Retinoic Acid: A Report from the Children’s Oncology Group

Por Park, Julie R., Villablanca, Judith G., London, Wendy B., Gerbing, Robert B., Haas-Kogan, Daphne, Stanton Adkins, E., Attiyeh, Edward F., Maris, John M., Seeger, Robert C., Patrick Reynolds, C., Matthay, Katherine K.
Publicado em 2009